Plexium Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 52

Employees

  • Latest Deal Type
  • Series C

  • Latest Deal Amount
  • $60.1M

  • Investors
  • 17

Plexium General Information

Description

Developer of protein-degrading therapeutics designed to treat cancer and other serious diseases. The company identifies novel small molecules that redirect ligases to targets of interest or induce degradation of targets by directly binding to them, enabling the medical community to combat cancer and inflammatory diseases in an improved manner.

Contact Information

Website
www.plexium.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 9330 Scranton Road
  • Suite 500
  • San Diego, CA 92121
  • United States
+1 (858)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 9330 Scranton Road
  • Suite 500
  • San Diego, CA 92121
  • United States
+1 (858)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Plexium Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series C) 25-Aug-2025 $60.1M Completed Clinical Trials - Phase 1
3. Later Stage VC (Series B) 28-Feb-2022 Completed Clinical Trials - Phase 1
2. Early Stage VC (Series A) 21-Jan-2021 $63M $63M Completed Clinical Trials - Phase 1
1. University Spin-Out 01-Jan-2017 Completed Startup
To view Plexium’s complete valuation and funding history, request access »

Plexium Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C
Series B
Series A-2
Series A-1 67,584,764 $0.000010 $0.04 $0.04 1x $0.04 2.48%
Series A 274,051,339 $0.000010 $0.07 $0.07 1x $0.07 10.04%
To view Plexium’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Plexium Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of protein-degrading therapeutics designed to treat cancer and other serious diseases. The company identifies
Drug Discovery
San Diego, CA
52 As of 2025

Madison, WI
 

Houston, TX
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Plexium Competitors (43)

One of Plexium’s 43 competitors is Centrose, a Venture Capital-Backed company based in Madison, WI.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Centrose Venture Capital-Backed Madison, WI
ImmunoGenesis Venture Capital-Backed Houston, TX
Arvinas Formerly VC-backed New Haven, CT
Apexian Pharmaceuticals Venture Capital-Backed Indianapolis, IN
Citryll Venture Capital-Backed Oss, Netherlands
You’re viewing 5 of 43 competitors. Get the full list »

Plexium Patents

Plexium Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026174209-A2 Ikzf2 positive biomarkers in cancer treatment Pending 14-Feb-2025
WO-2026136588-A1 Degraders of swi/snf-related matrix-associated actin-dependent regulator of chromatin subfamily a Pending 18-Dec-2024
WO-2026102277-A1 Combination therapies comprising ikzf2 degrader compounds Pending 08-Nov-2024
WO-2026064643-A1 Compounds, compositions, and methods of use thereof Pending 20-Sep-2024
AU-2024376167-A1 Compounds and pharmaceutical compositions that degrade swi/snf-related matrix-associated actin-dependent regulator of chromatin subfamily a Pending 10-Nov-2023 C07D487/04
To view Plexium’s complete patent history, request access »

Plexium Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Plexium Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds
aMoon Fund Venture Capital Minority
BVF Partners Hedge Fund Minority
Pappas Capital Venture Capital Minority
RA Capital Management Asset Manager Minority
SoftBank Investment Advisers Growth/Expansion Minority
You’re viewing 5 of 17 investors. Get the full list »

Plexium FAQs

  • When was Plexium founded?

    Plexium was founded in 2017.

  • Where is Plexium headquartered?

    Plexium is headquartered in San Diego, CA.

  • What is the size of Plexium?

    Plexium has 52 total employees.

  • What industry is Plexium in?

    Plexium’s primary industry is Drug Discovery.

  • Is Plexium a private or public company?

    Plexium is a Private company.

  • What is the current valuation of Plexium?

    The current valuation of Plexium is .

  • What is Plexium’s current revenue?

    The current revenue for Plexium is .

  • How much funding has Plexium raised over time?

    Plexium has raised $225M.

  • Who are Plexium’s investors?

    aMoon Fund, BVF Partners, Pappas Capital, RA Capital Management, and SoftBank Investment Advisers are 5 of 17 investors who have invested in Plexium.

  • Who are Plexium’s competitors?

    Centrose, ImmunoGenesis, Arvinas, Apexian Pharmaceuticals, and Citryll are some of the 43 competitors of Plexium.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process